Lv2
170 积分 2020-08-14 加入
ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage
1个月前
已完结
Advances in systemic therapy for non-small cell lung cancer
1个月前
已完结
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
1个月前
已完结
Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions
1个月前
已完结
The Role of Hedgehog Signaling in Non-small Cell Lung Cancer: Targeting Tumor Invasion, Therapy Resistance and Novel Therapeutic Strategies
1个月前
已完结
Optimizing KRAS Therapeutics for Non–Small Cell Lung Cancer
1个月前
已完结
Targeting MET in EGFR-mutated NSCLC
1个月前
已完结
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
1个月前
已完结
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis
1个月前
已完结
Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan
1个月前
已关闭
皖公网安备34019202002308
